AAAAAA

   
Results: 1-12 |
Results: 12
PHARMACOKINETICS AND PHARMACODYNAMICS OF SCOPOLAMINE AFTER SUBCUTANEOUS ADMINISTRATION
Authors: EBERT U SIEPMANN M OERTEL R WESNES KA KIRCH W
Citation: U. Ebert et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SCOPOLAMINE AFTER SUBCUTANEOUS ADMINISTRATION, Journal of clinical pharmacology, 38(8), 1998, pp. 720-726
DISPOSITION, ELIMINATION AND HEMODYNAMIC-EFFECTS OF VERAPAMIL AND TRANDOLAPRIL IN PATIENTS WITH FATTY LIVER-DISEASE
Authors: SIEPMANN M RAO BR KIRCH W
Citation: M. Siepmann et al., DISPOSITION, ELIMINATION AND HEMODYNAMIC-EFFECTS OF VERAPAMIL AND TRANDOLAPRIL IN PATIENTS WITH FATTY LIVER-DISEASE, Clinical drug investigation, 14(5), 1997, pp. 376-382
RETENTION OF URINE UNDER RISPERIDON
Authors: SIEPMANN M OLBRICH H
Citation: M. Siepmann et H. Olbrich, RETENTION OF URINE UNDER RISPERIDON, Psychiatrische Praxis, 24(4), 1997, pp. 209-209
CORONARY ANOMALY IN BEHCETS-SYNDROME
Authors: SIEPMANN M KIRCH W
Citation: M. Siepmann et W. Kirch, CORONARY ANOMALY IN BEHCETS-SYNDROME, Rheumatology international, 17(1), 1997, pp. 39-42
DRUG-INDUCED CEREBROVASCULAR ATTACKS
Authors: EBERT U SIEPMANN M KIRCH W
Citation: U. Ebert et al., DRUG-INDUCED CEREBROVASCULAR ATTACKS, Medizinische Klinik, 91(1), 1996, pp. 36-38
NON-INTERACTION OF TEMOCAPRIL, AN ACE-INHIBITOR, WITH WARFARIN
Authors: SIEPMANN M KIRCH W KLEINBLOESEM CH
Citation: M. Siepmann et al., NON-INTERACTION OF TEMOCAPRIL, AN ACE-INHIBITOR, WITH WARFARIN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 106-106
DISPOSITION, ELIMINATION AND HEMODYNAMIC-EFFECTS OF GALLOPAMIL IN PATIENTS WITH FATTY LIVER-DISEASE
Authors: SIEPMANN M RAO BR KIRCH W
Citation: M. Siepmann et al., DISPOSITION, ELIMINATION AND HEMODYNAMIC-EFFECTS OF GALLOPAMIL IN PATIENTS WITH FATTY LIVER-DISEASE, Clinical drug investigation, 10(6), 1995, pp. 337-343
THE INTERACTION OF THE CALCIUM-ANTAGONIST RO-40-5967 WITH DIGOXIN
Authors: SIEPMANN M KLEINBLOESEM C KIRCH W
Citation: M. Siepmann et al., THE INTERACTION OF THE CALCIUM-ANTAGONIST RO-40-5967 WITH DIGOXIN, British journal of clinical pharmacology, 39(5), 1995, pp. 491-496
HEMOLYSIS ON INTRAVENOUS ADMINISTRATION OF A NEW CALCIUM-ANTAGONIST
Authors: KLEINBLOESEM CH SIEPMANN M KIRCH W
Citation: Ch. Kleinbloesem et al., HEMOLYSIS ON INTRAVENOUS ADMINISTRATION OF A NEW CALCIUM-ANTAGONIST, Journal of cardiovascular pharmacology, 25(6), 1995, pp. 855-858
EFFECTS OF CAFFEINE ON THE DYNAMIC QUANTITATIVE TOPOGRAPHICAL EEG
Authors: SIEPMANN M EBERT U KIRCH W
Citation: M. Siepmann et al., EFFECTS OF CAFFEINE ON THE DYNAMIC QUANTITATIVE TOPOGRAPHICAL EEG, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 208-208
KERATOCONJUNCTIVITIS SICCA DURING SYSTEMI C TREATMENT WITH BETA-RECEPTOR BLOCKERS
Authors: SIEPMANN M BARTH J KIRCH W
Citation: M. Siepmann et al., KERATOCONJUNCTIVITIS SICCA DURING SYSTEMI C TREATMENT WITH BETA-RECEPTOR BLOCKERS, Deutsche Medizinische Wochenschrift, 119(51-52), 1994, pp. 1783-1785
CIMETIDINE IN THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA
Authors: SIEPMANN M STOLZEL U SIEG I LEOROSSBERG I RIECKEN EO DOSS MO
Citation: M. Siepmann et al., CIMETIDINE IN THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA, Zeitschrift fur Gastroenterologie, 31(4), 1993, pp. 246-249
Risultati: 1-12 |